feed,title,long_url,short_url
Benzinga,Axcella's First-of-Its-Kind NASH Treatment Shows Promising Early Results in Human Trials,https://benzinga.com/news/21/09/22867355/axcellas-first-of-its-kind-nash-treatment-shows-promising-early-results-in-human-trials,https://j.mp/2X3I53c
Benzinga,A Look Into Financial Services Sector Value Stocks,https://benzinga.com/news/21/09/22867222/a-look-into-financial-services-sector-value-stocks,https://j.mp/3hhMDd4
Benzinga,"JJill Reports Q2 Results, Dodges Outlook, Expects Supply Chain Disruption",https://benzinga.com/news/earnings/21/09/22865478/jjill-reports-q2-results-dodges-outlook-expects-supply-chain-disruption,https://j.mp/2XddKit
